drugset / Trial / NCT00002241

Safety and Effectiveness of an Anti-HIV Drug Combination Taken Twice Daily

NCT00002241 ↗

Phase 2 Unknown 80 enrolled Merck Sharp & Dohme LLC
Treatment

Summary

The purpose of this study is to see whether taking indinavir (IDV) plus ritonavir (RTV) plus stavudine (d4T) plus lamivudine (3TC) 2 times each day is safe and can lower the level of HIV in the blood.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject INDINAVIR ANHYDROUS Other / unclassified 800 mg —
Subject Lamivudine Other / unclassified — —
Subject Ritonavir Other / unclassified 100 mg —
Subject Stavudine Other / unclassified — —